GlassScriptPhysician profile
Michael C Foster
NPI 1780625269
$22,807.24
in general payments reported to CMS, 2019-2025
34 companies · $3,679 in 2025
The $3,679 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,472 · 2020: $623 · 2021: $809 · 2022: $370 · 2023: $9,327 · 2024: $1,526 · 2025: $3,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $5,266 · Travel and Lodging: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $5,265.89 |
| Travel and Lodging | $2,666.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $8,553.50 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $4,889.84 | 2019-2020 | |
| Boston Scientific Corporation | $3,438.37 | 2019-2025 | Avvigo Guidance System, Opticross, General - Vascular Access |
| Medtronic, INC. | $1,759.40 | 2024-2025 | Symplicity G3, Corevalve Evolut R |
| Abiomed | $751.79 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $496.65 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $432.65 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $305.57 | 2019-2024 | Farxiga |
| Amgen INC. | $262.83 | 2019-2025 | Repatha, Repatha |
| Teleflex LLC | $227.91 | 2025 | Turnpike, Supercross, Vascband |
| Janssen Pharmaceuticals, INC | $202.84 | 2019-2021 | |
| Recor Medical INC | $187.86 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Edwards Lifesciences Corporation | $138.86 | 2025 | Sapien 3 Ultra Resilia |
| Cardiva Medical, INC. | $138.71 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $136.54 | 2023 | Barostim Neo System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $107.35 | 2025 | Zepbound |
| Abbott Laboratories | $106.44 | 2020-2025 | Navitor |
| Pfizer INC. | $83.00 | 2019-2025 | |
| Philips North America LLC | $79.28 | 2019-2024 | (Bq9) Coronary Ivus |
| Cardinal Health 200 LLC | $67.93 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $63.04 | 2021-2022 | |
| Inari Medical, INC. | $62.46 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $44.70 | 2019-2025 | Camzyos |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $42.28 | 2019 | |
| Penumbra, INC. | $41.49 | 2025 | Indigo System |
| Grifols USA, LLC | $39.28 | 2021 | |
| Irhythm Technologies, INC. | $24.73 | 2024 | Zio Monitor, Zio Xt Patch |
| Livanova USA, INC. | $20.62 | 2019 | |
| Cardiovascular Systems INC. | $19.34 | 2019-2020 | |
| Novo Nordisk INC | $18.73 | 2025 | Wegovy |
| Cordis US Corp. | $18.65 | 2025 | Mynx Control |
| Terumo Medical Corporation | $17.94 | 2024 | Glidewire |
| Sanofi-Aventis U.S. LLC | $15.38 | 2019 | |
| Chiesi USA, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.